US Covid-19 vaccine on track for next month

The chairman of American vaccine maker Moderna says Canada is near the front of the line to receive 20 million doses of the COVID-19 vaccine it pre-ordered.

Noubar Afeyan offered that assessment today in an interview with CBC’s Rosemary Barton Live.

Afeyan’s remarks come as the Trudeau government has come under fire this past week for its ability to deliver a timely vaccine to Canadians.

https://www.disability-benefits-help.org/node/11207

https://www.disability-benefits-help.org/node/11237

https://www.disability-benefits-help.org/node/11235

https://www.disability-benefits-help.org/node/11233

https://www.disability-benefits-help.org/node/11232

https://www.disability-benefits-help.org/node/11230

https://www.disability-benefits-help.org/node/11245

https://www.disability-benefits-help.org/node/11259

https://www.disability-benefits-help.org/node/11261

https://www.disability-benefits-help.org/node/11263

https://www.disability-benefits-help.org/node/11264

https://www.disability-benefits-help.org/node/11265

https://www.disability-benefits-help.org/node/11266

https://www.disability-benefits-help.org/node/11268

https://www.disability-benefits-help.org/node/11270

https://www.disability-benefits-help.org/node/11271

Prime Minister Justin Trudeau created a firestorm when he said Canadians will have to wait a bit to get vaccinated for COVID-19 because the first doses off the production lines will be used in the countries where they are made.

Afeyan was asked whether the fact that Canada committed to pre-purchase its doses before other jurisdictions means it will get its supply first.

Afeyan confirmed that was the case.

“The people who are willing to move early on with even less proof of the efficacy have assured the amount of supply they were willing to sign up to,” he said.

“In the case of Canada, that number is about 20 million doses. But the Canadian government, like others, have also reserved the ability to increase that amount. And those discussions are ongoing,” he added.

Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach. US approval could be granted shortly after a Food and Drug Administration advisory meeting on December 10. Anthony Fauci, head of the US National Institute of Allergy and Infectious Diseases, told NBC on Sunday: “We likely, almost certainly, are going to be vaccinating a portion of the individuals in the first priority before the end of December.” German officials said over the weekend that preparations had been made to ensure that people could start getting inoculations next month, once the greenlight is given by European regulators. “As of today we are expecting it [the Pfizer/BioNTech vaccine] to be approved by mid-December,” Jens Spahn, Germany’s health minister, told Bavarian Radio.